Category: HCP Engagement

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

Minimizing Risks: A Guide to Ethical HCP Engagement

Ethical HCP engagement has become a crucial component of ensuring compliance and transparency in the interaction between healthcare professionals (HCPs) and life sciences companies. Engaging HCPs with integrity and following regulatory standards is essential for maintaining the trust of both the public and regulatory bodies, avoiding potential legal pitfalls and financial penalties. As regulatory scrutiny […]

The Facts About Open Payments Data in 2024

In the reporting year 2023, life sciences companies reported 15.64 million records totaling $12.75 billion in general and research payments, ownership/ investment interests to physicians, teaching hospitals, and other categories.   Over 11 years, the Open Payments program has published 84.05 million records, accounting for $72.80 billion in payments.  Reporting Open Payments Data to the Centers […]

5 Key Qualities of a Transparency Reporting Partner You Should Look For in 2025 

With regulations such as the U.S. Physician Payments Sunshine Act (Sunshine Act) mandating the disclosure of financial relationships with healthcare professionals (HCPs) and organizations (HCOs), ensuring compliance has never been more crucial.   As these reporting requirements grow more complex, life sciences companies are under pressure to find better ways to track, document, and report these […]

The Life Sciences Industry’s Regulatory Outlook in 2025

As we step into 2025, life sciences companies continue to push the boundaries of breakthrough innovations that improve patient health, all while adhering to the rules and regulations enacted by regulatory authorities. Identifying and mitigating compliance risks remains at the forefront of this transformation, especially with the industry’s top priorities that continue to evolve the […]

Transparency Reporting in Life Sciences: Unifying Efforts Across 5 Core Areas

Transparency reporting in life sciences is both a regulatory requirement and a crucial factor in maintaining trust within the life sciences, and healthcare industry. Driven by frameworks such as the Sunshine Act and the CMS Open Payments program, life sciences companies must disclose detailed data on financial interactions with healthcare professionals (HCPs) and organizations. While […]

Top 7 Key Areas of Focus for Effective Compliance Risk Analytics

Enterprise risk management has become a critical function for life sciences organizations. Primarily as it helps companies with risk detection and mitigation, enabling companies and compliance officers to effectively navigate the challenging regulatory terrain.  The complexity of applicable laws like the Anti-Kickback Statute (AKS) and the False Claims Act (FCA) make life sciences companies prone […]